Sort
21,281 grants matching “influenza”
Comparative Biomedical Scientist Training Program
$963,134Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2015 · CA
Anti-Influenza Therapy in Hospitalized Patients with Community-Acquired Pneumonia
$962,570Julio Alberto Ramirez · University Of Louisville · U18 · FY2011 · IP
A Preventative Adenoviral-Based H5N1 Influenza Vaccine
$962,378Andrea Gambotto · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · AI
Viral Arrays for Biodefense
$962,228W. Ian Lipkin · Columbia University Health Sciences · U01 · FY2007 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) - EMERGING PATHOGEN PROJECT
$962,066Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2016 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza
$961,771Daniel Hoft · Saint Louis University · N01 · FY2019 · AI
Systems Biology Approaches to Viral Pathogenesis and Immunity
$960,510Michael G Katze · Oregon Health & Science University · U54 · FY2011 · AI
MATERNAL IMMUNIZATION FOR THE PREVENTION OF INFECTIONS
$960,487Baylor College Of Medicine · N01 · FY2000 · AI
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$960,291Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$960,276Richard K. Plemper · Georgia State University · R01 · FY2022 · AI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$960,145Kathy L Rowlen · Indevr, Inc. · R44 · FY2014 · AI
Rapid Estimation of Influenza Vaccine Effectiveness in a Wisconsin Population Coh
$958,954Edward Belongia · Marshfield Clinic Research Foundation · U18 · FY2008 · IP
Influenza and Emerging Infectious Diseases
$958,408Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Core A: Protein Sciences
$958,363Neil King · University Of Washington · P01 · FY2022 · AI
Point-of-care Diagnosis and Surveillance of Known and Emerging Influenza Viruses
$957,836Timothy M Rose · Seattle Children'S Hospital · R01 · FY2018 · AI
A Handheld Microchip for GC analysis of breath to screen for COVID-19
$957,641Xiao-An Fu · University Of Louisville · U18 · FY2022 · TR
Core 3: Biocontainment Research Support Services Core
$957,509Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Data and analysis ecosystem for eukaryotic pathogen targeted sequencing
$957,169Bryan R Greenhouse · University Of California, San Francisco · U01 · FY2025 · AI
IDENTIFICATION AND CHARACTERIZATION OF T CELL EPITOPES FROM BACTERIAL PATHOGENS CAUSING PNEUMONIA
$956,427Bjoern Peters · La Jolla Institute For Immunology · N01 · FY2025 · AI
Agonists of the RIG-I Innate Immune Pathway
$956,404Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2012 · AI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections
$955,998Kevin S Harrod · University Of Alabama At Birmingham · R01 · FY2017 · AI
Center for Translational Pediatric Research
$955,666Alan Jackson Tackett · Arkansas Children'S Hospital Res Inst · P20 · FY2023 · GM
Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics
$955,395Kenneth C Bagley · Orlance, Inc. · R44 · FY2021 · AI
Advanced Development of a Universal Influenza Vaccine
$955,166Christopher Locher · Versatope Therapeutics, Inc. · N01 · FY2025 · AI
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$955,000Ramlee Rahmat · Ministry Of Health Malaysia · U50 · FY2006 · CI